BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo L, Bai Y, Ji S, Ma H. MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway. Int J Oncol 2019;54:807-20. [PMID: 30664191 DOI: 10.3892/ijo.2019.4689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Plousiou M, Vannini I. Non-Coding RNAs in Retinoblastoma. Front Genet 2019;10:1155. [PMID: 31798638 DOI: 10.3389/fgene.2019.01155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kim K, Ko Y, Oh H, Ha M, Kang J, Kwon EJ, Kang JW, Kim Y, Heo HJ, Kim G, Kim JW, Kim YH. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma. J Toxicol Environ Health A 2020;83:126-34. [PMID: 32114955 DOI: 10.1080/15287394.2020.1734891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li K, Han F, Wu Y, Wang X. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1. Onco Targets Ther 2021;14:3635-48. [PMID: 34113129 DOI: 10.2147/OTT.S302800] [Reference Citation Analysis]
4 Liu J, Hu HB, Liu YM, Li FX, Zhang LP, Liao ZM. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway. Mol Med Rep 2020;22:3667-76. [PMID: 33000231 DOI: 10.3892/mmr.2020.11452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Guo L, Bai Y, Ni T, Li Y, Cao R, Ji S, Li S. MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways. Int J Oncol 2021;59:47. [PMID: 34036380 DOI: 10.3892/ijo.2021.5227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nahon-esteve S, Martel A, Maschi C, Caujolle J, Baillif S, Lassalle S, Hofman P. The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice. CMM 2019;19:632-64. [DOI: 10.2174/1566524019666190726161044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Xu F, Liu G, Wang L, Wang X, Jin X, Bo W. miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway. Oncol Lett 2020;20:1952-60. [PMID: 32724440 DOI: 10.3892/ol.2020.11749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhang D, Wang L, Guo HL, Zhang ZW, Wang C, Chian RC, Zhang ZF. MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway. Int J Mol Med 2020;46:2078-88. [PMID: 33125090 DOI: 10.3892/ijmm.2020.4749] [Reference Citation Analysis]
9 Cheng B, Rong A, Zhou Q, Li W. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. J Exp Clin Cancer Res 2020;39:5. [PMID: 31900207 DOI: 10.1186/s13046-019-1510-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
10 García-Martínez A, Fuentes-Fayos AC, Fajardo C, Lamas C, Cámara R, López-Muñoz B, Aranda I, Luque RM, Picó A. Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors. J Clin Med 2020;9:E1838. [PMID: 32545591 DOI: 10.3390/jcm9061838] [Reference Citation Analysis]
11 Song W, Wang K, Yang X, Dai W, Fan Z. Long non‑coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR‑338‑3p. Int J Mol Med 2020;46:1377-88. [PMID: 32945416 DOI: 10.3892/ijmm.2020.4687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Roncarati R, Lupini L, Shankaraiah RC, Negrini M. The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer. Front Oncol 2019;9:988. [PMID: 31612113 DOI: 10.3389/fonc.2019.00988] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]